BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 15557299)

  • 1. Real-time imaging with the sonographic contrast agent SonoVue: differentiation between benign and malignant hepatic lesions.
    von Herbay A; Vogt C; Willers R; Häussinger D
    J Ultrasound Med; 2004 Dec; 23(12):1557-68. PubMed ID: 15557299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Characterization of focal liver lesions with contrast-enhanced low MI real time ultrasound and SonoVue].
    Hohmann J; Skrok J; Puls R; Albrecht T
    Rofo; 2003 Jun; 175(6):835-43. PubMed ID: 12811698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contrast-enhanced ultrasound with SonoVue: differentiation between benign and malignant focal liver lesions in 317 patients.
    von Herbay A; Westendorff J; Gregor M
    J Clin Ultrasound; 2010 Jan; 38(1):1-9. PubMed ID: 19790253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of focal liver lesions with contrast-specific US modes and a sulfur hexafluoride-filled microbubble contrast agent: diagnostic performance and confidence.
    Quaia E; Calliada F; Bertolotto M; Rossi S; Garioni L; Rosa L; Pozzi-Mucelli R
    Radiology; 2004 Aug; 232(2):420-30. PubMed ID: 15286314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentiation between benign and malignant hepatic lesions: utility of color stimulated acoustic emission with the microbubble contrast agent Levovist.
    von Herbay A; Vogt C; Häussinger D
    J Ultrasound Med; 2004 Feb; 23(2):207-15. PubMed ID: 14992357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential patterns of contrast enhancement in different focal liver lesions after injection of the microbubble US contrast agent SonoVue.
    Quaia E; Degobbis F; Tona G; Mosconi E; Bertolotto M; Pozzi Mucelli R
    Radiol Med; 2004 Mar; 107(3):155-65. PubMed ID: 15031681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulse inversion sonography in the early phase of the sonographic contrast agent Levovist: differentiation between benign and malignant focal liver lesions.
    von Herbay A; Vogt C; Häussinger D
    J Ultrasound Med; 2002 Nov; 21(11):1191-200. PubMed ID: 12418760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of focal liver lesions using contrast-enhanced sonography with a low mechanical index mode and a sulfur hexafluoride-filled microbubble contrast agent.
    Xu HX; Liu GJ; Lu MD; Xie XY; Xu ZF; Zheng YL; Liang JY
    J Clin Ultrasound; 2006; 34(6):261-72. PubMed ID: 16788957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of diagnostic performance of unenhanced vs SonoVue - enhanced ultrasonography in focal liver lesions characterization. The experience of three Italian centers.
    Quaia E; Stacul F; Gaiani S; Ricci P; Passariello R; Curzio D; Pozzi Mucelli R
    Radiol Med; 2004; 108(1-2):71-81. PubMed ID: 15269691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Importance of evaluating all vascular phases on contrast-enhanced sonography in the differentiation of benign from malignant focal liver lesions.
    Nicolau C; Vilana R; Catalá V; Bianchi L; Gilabert R; García A; Brú C
    AJR Am J Roentgenol; 2006 Jan; 186(1):158-67. PubMed ID: 16357396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentiation of benign from malignant focal splenic lesions using sulfur hexafluoride-filled microbubble contrast-enhanced pulse-inversion sonography.
    Stang A; Keles H; Hentschke S; von Seydewitz CU; Dahlke J; Malzfeldt E; Braumann D
    AJR Am J Roentgenol; 2009 Sep; 193(3):709-21. PubMed ID: 19696284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-specific vascularization pattern of liver metastasis, hepatocellular carcinoma, hemangioma and focal nodular hyperplasia in the differential diagnosis of 1,349 liver lesions in contrast-enhanced ultrasound (CEUS).
    Strobel D; Seitz K; Blank W; Schuler A; Dietrich CF; von Herbay A; Friedrich-Rust M; Bernatik T
    Ultraschall Med; 2009 Aug; 30(4):376-82. PubMed ID: 19688669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Late-phase pulse-inversion sonography using the contrast agent levovist: differentiation between benign and malignant focal lesions of the liver.
    von Herbay A; Vogt C; Häussinger D
    AJR Am J Roentgenol; 2002 Nov; 179(5):1273-9. PubMed ID: 12388513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. US characterization of focal hepatic lesions with intermittent high-acoustic-power mode and contrast material.
    Quaia E; Bertolotto M; Calderan L; Mosconi E; Mucelli RP
    Acad Radiol; 2003 Jul; 10(7):739-50. PubMed ID: 12862283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contrast-enhanced ultrasonography with SonoVue: differentiation between benign and malignant lesions of the spleen.
    von Herbay A; Barreiros AP; Ignee A; Westendorff J; Gregor M; Galle PR; Dietrich C
    J Ultrasound Med; 2009 Apr; 28(4):421-34. PubMed ID: 19321670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unclear focal liver lesions in contrast-enhanced ultrasonography--lessons to be learned from the DEGUM multicenter study for the characterization of liver tumors.
    Bernatik T; Seitz K; Blank W; Schuler A; Dietrich CF; Strobel D
    Ultraschall Med; 2010 Dec; 31(6):577-81. PubMed ID: 20740399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of small focal liver lesions using real-time contrast-enhanced sonography: diagnostic performance analysis in 200 patients.
    Xu HX; Liu GJ; Lu MD; Xie XY; Xu ZF; Zheng YL; Liang JY
    J Ultrasound Med; 2006 Mar; 25(3):349-61. PubMed ID: 16495496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparative diagnostic value of computed tomography and contrast-enhanced ultrasonography in diagnosis of focal liver lesions].
    Zviniene K; Zaboriene I; Basevicius A; Pundzius J
    Medicina (Kaunas); 2009; 45(10):751-63. PubMed ID: 19996661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Value of contrast-enhanced sonography for the characterization of focal hepatic lesions in patients with diffuse liver disease: receiver operating characteristic analysis.
    Kim SH; Lee JM; Lee JY; Han JK; An SK; Han CJ; Lee KH; Hwang SS; Choi BI
    AJR Am J Roentgenol; 2005 Apr; 184(4):1077-84. PubMed ID: 15788576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Contrast-enhanced "low MI real-time" sonography for the assessment of the malignancy of focal liver lesions].
    Strunk H; Börner N; Stuckmann G; Fröhlich E; Hadizadeh D
    Rofo; 2005 Oct; 177(10):1394-404. PubMed ID: 16170709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.